Jun 30, 2021

Entrada Therapeutics Q2 2021 Earnings Report

EPS
-$7.49
Previous year: -$5.18
+44.6%
Cash and Equivalents
$137M
Free Cash Flow
-$9.45M

Entrada Therapeutics

Entrada Therapeutics